NSHA ANTIMICROBIAL STEWARDSHIP PROGRAM. Quarterly Report Q1 2018/19
|
|
- Morgan Ferguson
- 5 years ago
- Views:
Transcription
1 NSHA ANTIMICROBIAL STEWARDSHIP PROGRAM Quarterly Report Q1 2018/19 Sep 16, 2018
2 Table of Contents Summary... 1 NSHA ASP Structure... 2 Interventions... 2 Results & Metrics... 4 Education Research Guidelines Microbiology Other Activities Strategic Planning Acknowledgements... 14
3 Summary The vision of the NSHA Antimicrobial Stewardship Program (ASP) is to ensure the safe and effective use of antimicrobial agents in patients cared for in Nova Scotia Health Authority. NSHA s ASP will aim to improve patient care by modelling and promoting best antimicrobial use practices. Over time, effective ASPs influence the culture of antimicrobial use by changing behaviors of physicians, pharmacists, nurses, students, patients and their families. The NSHA ASP will aim to: Promote a culture of optimal antibiotic use in NSHA Respect and promote regional strengths Act in collaborative and engaging manner Make evidence-based recommendations Maintain an open/transparent program Start small, build on success The NSHA ASP team was fully formed in the July Our early activities have focused on forming the structure of the program and surveying the current Antimicrobial Stewardship (AMS) activities throughout NSHA. A significant focus has been placed on our communication strategy and presentations to introduce the NSHA ASP to all healthcare workers. In addition, our ASP pharmacists have been receiving Infectious Diseases and AMS training through online courses and observerships within NSHA and abroad. We have established zonal subcommittees with oversight by the NSHA ASP Steering Committee (see organizational chart below). These committees are multidisciplinary including pharmacists, physicians (representing a variety of services), microbiology, nursing, infection prevention and control (IPAC), and quality improvement. A strategic plan has been developed and approved by our sponsors. This plan outlines the vision, structure, and planned initiatives of this program. There is cross representation on the NSHA Antimicrobial Subcommittee. The Strategic Plan is currently being updated for the next 3 years. In addition, we have spent significant time obtaining quality, validated antimicrobial use, process, and outcomes measures. This task has been complicated by different electronic medical record (EMR) systems across NSHA. We have been working with Meditech to obtain reliable dispensing data (Defined Daily Dose (DDD) and/or Days of Therapy (DOT)) outside of Central Zone. The DOT reports have been finalized and are available in this report. The DDD reports are nearly finalized and should be available for the next quarter. Within Central Zone, DDD and cost data is available. Once we have obtained dispensing AMU data, data will be validated over the next 6 to 12 months using secondary data sources and manual chart review. We have initiated NSHA-wide initiatives based on baseline stewardship activities, level of ASP pharmacist training, and a point prevalence survey conducted in 2015 (Black E, Neville H, Losier M, Harrison M, Abbass K, Slayter K, Johnston K, Sketris I. CPJ. 2017; 150(4):S35) We have successfully met the five tests for compliance for the Accreditation Canada Antimicrobial Stewardship required organizational practice (ROP). 1
4 NSHA ASP Structure Interventions The main clinical focus of the NSHA ASP is prospective audit and feedback with academic detailing. Prospective audit and feedback (PAF) is a core clinical strategy of ASPs. PAF occurs in two intensive care units in the Eastern Zone (Cape Breton Regional ICU and CCU). In Northern Zone (Colchester East Hants Health Centre) specific antimicrobials are targeted throughout the hospital. In Central Zone, PAF was initiated in the two medical surgical ICUs (Victoria General (VG) and Halifax Infirmary (HI) sites). For Western Zone, PAF includes the Valley Regional Hospital (VRH) ICU and bacteriuria among inpatients. The NSHA Pharmacist Initiated IV to PO Conversion of Antimicrobials Policy and Procedure was implemented in July/August 2017 with the plan to measure clinical pharmacist utilization and changes in IV rates over time. A Redundant Antimicrobial Therapy Policy has been developed and is now awaiting approval by the Antibiotic Subcommittee (ASC) and Drugs and Therapeutics (D&T). 2
5 A NSHA Antimicrobial Handbook is being developed and designed (see Guidelines below). With the amalgamation of health authorities, there has been the need to review the formularies across the province. We have done a review of these formularies to streamline the unified NSHA formulary. Guidelines for appropriate use of 36 antimicrobials have been developed and are awaiting approval by ASC and D&T. Collaborating with Dalhousie Academic Detailing services to update outpatient antibiotic guidelines for common infections in the community. The planned competition date is November Pre-printed Order (PPO) management is handled through representation on NSHA Antimicrobial Subcommittee (ASC) of the Drugs and Therapeutics Committee. Zone IV to PO PAF SUMMARY OF INTERVENTIONS Handbook Guidelines Antibiogram Formulary Review Cascading sensitivities Eastern CBRH Western VRH Northern Colchester Central HI/VG PAF: prospective audit and feedback Future interventions are currently being developed as part of our strategic plan. 3
6 Results & Metrics Website traffic: April: 367 page views (299 unique views) 18% decrease from March May: 436 page views (362 unique views) 16% increase from April June: 476 page views (380 unique views) 9% increase from May Website Use 0 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Page views Unique Page views NORTHERN Colchester AMS PAF Intervention Outcomes FY QTR1: Total Number of Interventions (April 1 st to June 30 th 2018): 15 Agree: 33%; Disagree: 27%; AMS Team Agreed with Intervention (Continue Therapy): 40% PAF Outcomes CEHHC FY 2017/2018 Q1 Type of Service Attending PAF Cases Continue 40% Agree 33% Hospitalist 47% Surgeon 53% Disagree 27% 4
7 Cumberland NUMBER OF SUGGESTED CHANGES BY CATEGORY OF RECOMMENDATION NUMBER OF SUGGESTED CHANGES DOSE CHANGE DRUG CHANGE IV TO PO STOP DRUG ACCEPTANCE OF SUGGESTIONS 69% 16% 16% NO YES NOT TRACKED 5
8 EASTERN In Eastern Zone, the antimicrobial interventions performed by clinical pharmacists is recorded in Meditech. 1st Quarter 2018 Renal/hepatic dose adjustment Labs/imaging recommended Escalate therapy Dose optimization De-escalation Duration optimization Change empiric therapy IV to PO Discontinue abx No. accepted No. pharmacist interventions Total documented antimicrobial-related interventions: 191 Total accepted interventions: 151* (see next two bullets) Not included in table: 9 allergy interventions / confirmations documented resulted in either monitoring or change of therapy; not recorded as accepted because n/a Renal / Hepatic interventions: Interventions recorded by pharmacists to confirm appropriate dosing are not recorded as MD accepted because a change to the original antimicrobial order was not required. However, they are recorded as part of the total no. of interventions. Antimicrobial indications recorded / documented on the patient Meditech profile: Total for Zone: 753 6
9 Western Zone AMS Acceptance Rates Dose Drug Duration Deescalation Discontinuation Total Total Accepted Acceptance Rate = 96% Days of Therapy (DOT) Days of therapy is a metric used to measure consumption of antimicrobials. It represents simply the number of days that patient is on an antibiotic, regardless of the dose. This makes it advantageous over Defined Daily Doses in renal dysfunction as well as pediatric populations. The following tables report the DOT collectively for the zones of Eastern, Northern and Western. It contains use of antimicrobials for admitted patients. It would exclude the doses of antimicrobials that would be given in the ER prior to admission and doses of given in the OR for surgical prophylaxis. 7
10 DOT / 100 BED DAYS 9 8 EZ NZ WZ CEFTRIAXONE/ CEFOTAXIME METRONIDAZOLE LEVOFLOX/MOXIFLOX PIPTAZO CEFAZOLIN CIPROFLOXACIN AMOXCLAV VANCOMYCIN CEPHALEXIN AZITHRO/CLARITHRO CEFUROXIME DOXYCYCLINE AMOXICILLIN TMP-SMX AMPICILLIN MEROPENEM NITROFURANTOIN Total DOT/100 BED DAYS by Quarter EZ NZ WZ Q4 2017/18 Q1 2018/19 CENTRAL Biofire Trial The Biofire uses multiplex PCR to provide early identification of bacteria and some resistance mechanisms including: MRSA (meca), VRE (vana/b), and Klebsiella pneumoniae carbapenemase (KPC). The AMS team in Central Zone did a trial to identify if earlier identification of microorganisms and feedback to prescribers with results could impact antimicrobial prescribing. Study Period Feb 2018 May positive blood cultures reviewed by AMS team 73% of interventions were narrowing antimicrobial therapy 8
11 When AMS recommendations were accepted 57% of patients received cefazolin as final therapy Median duration of antibiotic use was shorter when AMS intervention was accepted ASP started PAF in mid-july 2017 (Q2) at VG and HI ICUs. Below we summarize the 5 most commonly used antimicrobials for Q1 in each ICU (per DDD/100 bedday). In addition, we graphed the use of broad spectrum antimicrobials by quarter. Finally, we included tables of overall antimicrobial use and cost by quarter. VG ICU: There is an ongoing downward trend in all antibiotic use including piptazo and meropenem. Vancomycin has decreased as well. Total cost has decreased consistently. HI ICU: Overall antibiotic use has increased from last quarter although cost slightly decreased. There was more broad-spectrum use, particularly meropenem. Much of this use was for a few patients with cystic fibrosis receiving high doses and multi-drug therapy. 9
12 VG ICU VG ICU TOP 5 ANTIMICROBIALS Q1 Rank Drug Route DDD/100 bedday Cost/100 bedday 1 Vancomycin IV Piptazo IV Cloxacillin IV Fluconazole IV Cefazolin IV VG ICU Antimicrobial Summary Total Antimicrobial Cost Total Antimicrobial costs/ Total Antimicrobial DDDs/ 100 beddays 100 bed days FY17-18 Q1 $26,709 $4, Q2 $13,389 $2, Q3 $10,549 $1, Q4 $15,529 $2, FY18-19 Q1 $11,543 $2, Systemic Antibacterial Systemic Antibacterial Systemic Antibacterial Cost costs/ 100 beddays DDDs/ 100 bed days FY17-18 Q1 $7,515 $1, Q2 $7,180 $1, Q3 $5,253 $ Q4 $7,223 $1, FY Q1 $4,091 $ Systemic Antifungal Cost Systemic Antifungal Systemic Antifungal costs/ 100 beddays DDDs/ 100 bed days FY17-18 Q1 $17,827 $2, Q2 $929 $ Q3 $4,396 $ Q4 $6,669 $1, FY18-19 Q1 $3,267 $ VG ICU DDD/100 BEDDAYS Q1 Q2 Q3 Q4 Q VG ICU (antifungals) DDD/100 BEDDAYS Q1 Q2 Q3 Q4 Q Piptazo Meropenem Vancomycin Ceftriaxone Cipro IV 0 Fluc IV Fluc PO Micafungin
13 HI ICU HI ICU TOP 5 ANTIMICROBIALS Q1 Rank Drug Route DDD/100 bedday Cost/100 bedday 1 Meropenem IV Cefazolin IV Vancomycin IV Ceftriaxone IV Piptazo IV HI ICU Antimicrobial Summary Total Antimicrobial Cost Total Antimicrobial costs/ Total Antimicrobial DDDs/ 100 beddays 100 bed days FY17-18 Q1 $10,513 $1, Q2 $12,674 $1, Q3 $10,711 $1, Q4 $16,267 $1, FY18-19 Q1 $14,278 $1, Systemic Antibacterial Systemic Antibacterial Systemic Antibacterial Cost costs/ 100 beddays DDDs/ 100 bed days FY17-18 Q1 $8,059 $ Q2 $10,179 $1, Q3 $8,553 $1, Q4 $10,279 $1, FY18-19 Q1 $11,124 $1, Systemic Antifungal Cost Systemic Antifungal Systemic Antifungal costs/ 100 beddays DDDs/ 100 bed days FY17-18 Q1 $753 $ Q2 $1,361 $ Q3 $778 $ Q4 $2,953 $ FY18-19 Q1 $1,325 $ HI ICU DDD/100 BEDDAYS 25 Q1 Q2 Q3 Q4 Q Piptazo Meropenem Vancomycin Ceftriaxone Cipro IV 11
14 Outcomes Data *Data not available, delay in reporting from Q1. Will include in next report. 12
15 Education Eastern Zone: Presentation on ESBL Education Session with Critical Care Nurses by EZ AMS Pharmacist AMS rotation for 1 Infectious Diseases Fellow Research Collaborating with Emily Black of Dalhousie Pharmacy Department for NSHA Research Foundation Establishment Grant: Optimizing Antimicrobial Stewardship Interventions to Improve Management of Urinary Tract Infections in Hospitalized Adults Project to modify laboratory reporting to minimize treatment of asymptomatic bacteriuria: Pilot Project to Reduce the Unnecessary Use of Antibiotics in Patients with Asymptomatic Bacteriuria Working to support a variety of residency (MD and pharmacy) research projects Developing a research proposal on Characterizing Outpatient Antimicrobial Use in Nova Scotia. This will use data collected in the Drug Information System to quantify antimicrobial use in Nova Scotia and develop feedback tools to prescribers. Guidelines NSHA Antimicrobial Handbook The formation of a NSHA Antimicrobial Handbook was initiated prior to the formation of the NSHA ASP by the Central Antimicrobial Agents Subcommittee. This handbook will provide guidance on antimicrobial use for a broad range of syndromes. It will also include information on best practices, therapeutic drug monitoring, and surgical prophylaxis. Updates will be done by priority of topic to facilitate workflow and approval. The first topic (Staphylococcus aureus bacteremia) is approved and posted on the AMS website, Candida bloodstream infections, meningitis, aminoglycosides, vancomycin, asymptomatic bacteriuria, and uncomplicated cystitis are under review and waiting approval from ASC. Academic detailing: collaborating to update the Dalhousie Academic Detailing curriculum for common outpatient Infectious Diseases syndromes. Microbiology Antibiogram for all zones have been updated and are posted on the AMS website. We are exploring options to stratify the antibiogram by patient location/type A template has been developed to unify antibiograms across NSHA. We have improved on our time to identification of blood culture isolates using rapid diagnostic technologies. This currently is being done with direct identification of positive blood culture bottles using our MALDI-TOF-MS in Central Zone. Developing a pilot project in conjunction with the Hospitalist Medicine Unit (8.4 at the Halifax Infirmary) to improve the processing of specimens in the microbiology lab to minimize reporting and treated for asymptomatic bacteriuria. Site visits to peripheral labs by Dr. Davis. Representation on the Susceptibility testing subcommittee of the Microbiology Service Advisory Committee Other Activities NSHA ASP website live on May 6, 2017 Frequently updated as material becomes available 13
16 Strategic Planning Collaborating with other Atlantic Canadian stewardship programs Collaborating with other Choosing Wisely Collaborate with Department of Health and Wellness (DHW) Nova Scotia AMS Co-Leads worked with World Health Organization (WHO) to develop an AMS toolkit for Low to Middle Income Countries. Acknowledgements Executive sponsors: Dr. Lynne Harrigan (VP Medicine & Integrated Health Services) and Colin Stevenson (VP Quality, System Performance and Transformation) Gail Blackmore (Senior Director Quality Improvement, Safety, Patient Relations), Dr. Steven Soroka (Senior Medical Director Pharmacy Services), and Glenn Cox (Senior Director Pharmacy Services) Dr. Todd Hatchette: Chief of the Division of Microbiology in the Department of Pathology and Laboratory Medicine Dr. Shelly McNeil, Division Head Infectious Diseases Tammy MacDonald, Central Zone Director, Quality Improvement, Safety & Patient Relations and NSHA Infection Prevention and Control Lead Heather Neville & Stephen MacKay, analyzing antibiotic use metrics Emily Black: collaborating and sharing study results SHS-UHN ASP: sharing resources, education of team members, and collaborations David Evans: Application Specialist Meditech Pharmacy Program 14
NSHA ANTIMICROBIAL STEWARDSHIP PROGRAM. Quarterly Report Q1 2017
NSHA ANTIMICROBIAL STEWARDSHIP PROGRAM Quarterly Report Q1 217 Sept 21, 217 Table of Contents Summary... 2 Interventions... 3 Results & Metrics... 4 Education... 12 Research... 13 Guidelines... 13 Other
More informationAntimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD
Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an
More informationImpact of Antimicrobial Stewardship Program
Impact of Antimicrobial Stewardship Program Ripal Joshi, Pharm.D. AAHIVP Tampa General Hospital January 28, 2016 Objectives Provide an overview on antimicrobial stewardship programs (ASP) Describe the
More informationAntimicrobial Stewardship. October 2012
Antimicrobial Stewardship October 2012 Rising Antimicrobial Resistance Methicillin resistant staphylococcus aureus (MRSA) Vancomycin resistant enterococci (VRE) MDR and extremely drug resistant (XDR TB)
More informationCommonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities
Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationPromoting Appropriate Antimicrobial Prescribing in Secondary Care
Promoting Appropriate Antimicrobial Prescribing in Secondary Care Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2015 Introduction Background ESPAUR
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationChallenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial
More informationHealthcare Facilities and Healthcare Professionals. Public
Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationAntimicrobial Stewardship 101
Antimicrobial Stewardship 101 Betty P. Lee, Pharm.D. Pediatric Infectious Disease/Antimicrobial Stewardship Pharmacist Lucile Packard Children s Hospital Stanford Disclosure I have no actual or potential
More informationSt. Joseph s General Hospital Vegreville. and. Mary Immaculate Care Centre. Antimicrobial Stewardship Report
St. Joseph s General Hospital Vegreville and Mary Immaculate Care Centre Antimicrobial Stewardship Report January to June 217 Introduction Antibiotics are among the most commonly prescribed medications
More informationANTIBIOTIC STEWARDSHIP
ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized
More informationMHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative
MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative Place picture here Nov. 14, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Please use the chat box to ask questions!
More informationBest Practices: Goals of Antimicrobial Stewardship
Best Practices: Goals of Antimicrobial Stewardship Gail Scully, M.D, M.P.H. and Elizabeth Radigan, PharmD, BCPS UMass Memorial Medical Center Division of Infectious Disease Department of Medicine September
More informationReady to Launch: Antimicrobial Stewardship for All!
Ready to Launch: Antimicrobial Stewardship for All! Lucas Schulz, PharmD, BCPS AQ ID Clinical Coordinator Infectious Diseases PGY2 Infectious Diseases Residency Program Director Disclosures Consultant
More informationAntibiotic Stewardship Program (ASP) CHRISTUS SETX
Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:
More informationCollecting and Interpreting Stewardship Data: Breakout Session
Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline
More informationAntimicrobial Stewardship Program 2 nd Quarter
Antimicrobial Stewardship Program 2 nd Quarter May 19, 2016 Jill Hanson, WHA DeAnn Richards, MetaStar Objectives for Today Hospital Highlight UnityPoint Health - Meriter Status of the state Update on pilot
More informationASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies
ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies Theresa Jaso, PharmD, BCPS (AQ-ID) Network Clinical Pharmacy Specialist Infectious Diseases Seton Healthcare Family Ascension
More informationAntimicrobial Stewardship in the Hospital Setting
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor
More informationHospital Antimicrobial Stewardship Program Assessment Checklist
Hospital Antimicrobial Stewardship Program Assessment Checklist This checklist should be used to determine which aspects of antimicrobial stewarship (AMS) programs are already in place to ensure optimal
More informationMisericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014
H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report July December 213 Second and Third Quarters
More informationSolution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim
Solution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim Program/Project Description, including Goals What was the problem to be solved? How was it identified? What baseline data existed?
More informationAntibiotic Resistance Oct 24, 2018
Antibiotic Resistance Oct 24, 2018 Paul Bonnar, FRCPC paule.bonnar@nshealth.ca Jason Reynolds jason.reynolds@nshealth.ca http://www.cdha.nshealth.ca/nsha-antimicrobial-stewardship No disclosures Off-label
More informationJump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
More informationExecutive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts
Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts Investigational Team: Diane Brideau-Laughlin BSc(Pharm),
More informationUpdates in Antimicrobial Stewardship
Updates in Antimicrobial Stewardship Andrew Hunter, Pharm.D., BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center andrew.hunter@va.gov Disclosures No disclosures
More informationGrey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report
H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report to 214 Table of Contents I. Introduction..
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required
More informationThe International Collaborative Conference in Clinical Microbiology & Infectious Diseases
The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of
More informationThe Three R s Rethink..Reduce..Rocephin
The Three R s Rethink..Reduce..Rocephin By: Alisa Cuff RN,BN,CIC and John Bautista B.Sc. (Chem), B.Sc.Pharm, M.Sc.Pharm IPAC National Conference 2017 Newfoundland and Labrador Regional Health Authorities
More informationANTIBIOTICS IN THE ER:
ANTIBIOTICS IN THE ER: EXPLORING THE ROLE OF ANTIMICROBIAL STEWARDSHIP IN THE EMERGENCY DEPARTMENT ANGELINA DAVIS, PHARMD, MS, BCPS (AQ-ID) LIAISON CLINICAL PHARMACIST DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH
More informationHot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital
Hot Topics in Antimicrobial Stewardship Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Antimicrobial Stewardship Goals Primary Goal Optimize clinical outcomes
More informationDefine evidence based practices for selection and duration of antibiotics to treat suspected or confirmed neonatal sepsis
GLOBAL AIM: Antibiotic Stewardship Perinatal Quality Improvement Teams (PQITs) will share strategies and lessons learned to develop potentially better practices and employ QI methodologies to establish
More informationWENDY WILLIAMS, MT(AMT) MSAH DIRECTOR LABORATORY AND PATHOLOGY SERVICES. Appalachian Regional Healthcare System apprhs.org
Incorporating Automation and Rapid Diagnostic Technologies into the Micro Lab's Lean Workflow to Boost Productivity, Shorten Length of Stay, and Improve Antibiotic Utilization WENDY WILLIAMS, MT(AMT) MSAH
More informationAntimicrobial Stewardship:
Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of
More informationANTIMICROBIAL STEWARDSHIP IN SCOTLAND. Key achievements of the Scottish Antimicrobial Prescribing Group
ANTIMICROBIAL STEWARDSHIP IN SCOTLAND Key achievements of the Scottish Antimicrobial Prescribing Group Dr Jacqueline Sneddon Project Lead Scottish Antimicrobial Prescribing Group Overview of talk ScotMARAP
More informationQuality indicators and outcomes in the devolved nations Scotland
Quality indicators and outcomes in the devolved nations Scotland Dr Jacqueline Sneddon, MRPharmS Project Lead, Scottish Antimicrobial Prescribing Group Federation of Infection Societies Conference Birmingham,
More informationMeasurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist
Measurement of Antimicrobial Drug Use Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist Defined Daily Dose Target Audience: Administrators and Epidemiologists Standardized definition
More informationAntimicrobial utilization: Capital Health Region, Alberta
ANTIMICROBIAL STEWARDSHIP Antimicrobial utilization: Capital Health Region, Alberta Regionalization of health care services in Alberta began in 1994. In the Capital Health region, restructuring of seven
More informationJump Start Stewardship
Jump Start Stewardship Webinar 2: Building your Stewardship Team and Selecting Interventions and Targets for your Implementation Welcome Thank you for your time today This webinar will be recorded for
More informationAntimicrobial Use Toolkit Webinar M A R C H 1 3,
Antimicrobial Use Toolkit Webinar M A R C H 1 3, 2 0 1 8 Welcome & Housekeeping Thank you for attending! HMS data abstractors Administrators QI staff Pharmacists Hospitalists ID physicians Individuals
More informationAntimicrobial stewardship
Antimicrobial stewardship Magali Dodemont, Pharm. with the support of Wallonie-Bruxelles International WHY IMPLEMENT ANTIMICROBIAL STEWARDSHIP IN HOSPITALS? Optimization of antimicrobial use To limit the
More informationPresenter: Marc Meyer, BPharm, RPh, CIC, FAPIC Clinical Pharmacists, Infection Preventionist, Antibiotic Stewardship Pharmacist Southwest Health
Presenter: Marc Meyer, BPharm, RPh, CIC, FAPIC Clinical Pharmacists, Infection Preventionist, Antibiotic Stewardship Pharmacist Southwest Health System, Cortez, Colorado None How do AU vendors and NHSN
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Annual Report 216-217 Prepared by the Fraser Health Antimicrobial Stewardship Program June 217 Contents Executive Summary... 3 Background... 4 ASP Team Members... 5 Ackowledgements...
More informationAntibiotic Stewardship in the Hospital Setting
Antibiotic Stewardship in the Hospital Setting G. Evans, MD FRCPC Medical Director, Infection Prevention & Control Kingston General Hospital & Hotel Dieu Hospital EOPIC September 26, 2012 Stewardship stew-ard-ship
More informationWhat is an Antibiotic Stewardship Program?
What is an Antibiotic Stewardship Program? Jane Rogers, R.N. Anne Messer, MPH Learning Session #4 August 15, 2017 National Nursing Home Quality Care Collaborative Change Package Change Bundle: To prevent
More informationHealthcare-associated Infections and Antimicrobial Use Prevalence Survey
Healthcare-associated Infections and Antimicrobial Use Prevalence Survey Shamima Sharmin, M.B.B.S., MSc, MPH Emerging Infections Program New Mexico Department of Health Agenda Recognize healthcare-associated
More informationCHAPTER 9 ANTIMICROBIAL STEWARDSHIP PROGRAM (ASP)
DEPARTMENT OF THE ARMY HEADQUARTERS, UNITED STATES ARMY MEDICAL DEPARTMENT ACTIVITY FORT POLK, LOUISIANA 71459-5110 MEDDAC Regulation 29 August 2017 Number 500a-59 CHAPTER 9 ANTIMICROBIAL STEWARDSHIP PROGRAM
More informationAntibiotic Stewardship in the LTC Setting
Antibiotic Stewardship in the LTC Setting Joe Litsey, Director of Consulting Services Pharm.D., Board Certified Geriatric Pharmacist Thrifty White Pharmacy Objectives Describe the Antibiotic Stewardship
More information1. List three activities pharmacists can implement to support. 2. Identify potential barriers to implementing antimicrobial
OPTIMIZING ANTIMICROBIAL STEWARDSHIP: IT STARTS IN THE EMERGENCY DEPARTMENT! 1 2 Objectives 1. List three activities pharmacists can implement to support health-system antimicrobial stewardship programs
More informationAdvances in Antimicrobial Stewardship (AMS) at University Hospital Southampton
Advances in Antimicrobial Stewardship (AMS) at University Hospital Southampton Dr Julian Sutton Consultant in Infectious Diseases & Medical Microbiology Federation of Infection Societies 1 st December,
More informationCurricular Components for Infectious Diseases EPA
Curricular Components for Infectious Diseases EPA 1. EPA Title Promoting antimicrobial stewardship based on microbiological principles 2. Description of the A key role for subspecialists is to utilize
More informationANTIMICROBIAL STEWARDSHIP PROGRAM ANNUAL REPORT How you want to be treated.
ANTIMICROBIAL STEWARDSHIP PROGRAM ANNUAL REPORT 2016-17 How you want to be treated. Table of Contents Executive Summary Background Team Clinical Activities Financials Appendix Return to Table of Contents
More informationGrey Nuns Community Hospital (GNCH) Antimicrobial Stewardship July December 2017
Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship July December 217 Table of Contents Table of Contents... 2 I. Executive Summary... 3 II. GNCH Total Antimicrobial Utilization... 4 III. GNCH
More informationUsing Data to Track Antibiotic Use and Outcomes
Using Data to Track Antibiotic Use and Outcomes Michelle Nemec, PharmD Thrifty White Drug Pharmacy Objectives Describe the Antibiotic Stewardship Core Element of tracking and the specific interventions
More informationDr. Charles Onunkwo, Infectious Disease Medicine Erika Ingram, Infectious Disease/Critical Care Clinical Pharmacy Specialist Southeastern Regional
Dr. Charles Onunkwo, Infectious Disease Medicine Erika Ingram, Infectious Disease/Critical Care Clinical Pharmacy Specialist Southeastern Regional Medical Center Cancer Treatment Centers of America May
More informationAntimicrobial Stewardship Strategy: Intravenous to oral conversion
Antimicrobial Stewardship Strategy: Intravenous to oral conversion Promoting the use of oral antimicrobial agents instead of intravenous administration when clinically indicated. Description This is an
More informationAntimicrobial Stewardship in Scotland
Antimicrobial Stewardship in Scotland UKCPA/FIS Scientific Meeting 18 th November 2010 Triumphs and Unintended Consequences Dr Jacqueline Sneddon Project Lead for Scottish Antimicrobial Prescribing Group
More informationANTIMICROBIAL STEWARDSHIP PROGRAM. Providence Health Care ANNUAL REPORT
ANTIMICROBIAL STEWARDSHIP PROGRAM Providence Health Care ANNUAL REPORT 2015 2016 T A B L E O F C O N T E N T S ASP ANNUAL REPORT 2015 2016 2 Clinical Activities 10 Executive Summary 3 Financials 24 Education
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationWorkplan on Antibiotic Usage Management
IMPACT Forum: Antibiotic Guideline in Perspective Workplan on Antibiotic Usage Management Dr. Raymond Yung Consultant Microbiologist PYNEH 20 April 2002 May 2002 Dr. Raymond Yung 1 Objective 1. Heighten
More information6/15/2017 PART 1: THE PROBLEM. Objectives. What is Antimicrobial Resistance? Conflicts of Interest Disclosure Statement
Conflicts of Interest Disclosure Statement Getting a grasp on Antibiotic Use and Resistance: Principles of Antimicrobial Stewardship Speaker has nothing to disclose. Jacob M Kesner, PharmD UNMH PGY-2 Infectious
More informationAntimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi
Antimicrobial Stewardship-way forward Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi Lets save what we have! What is Antibiotic stewardship? Optimal selection, dose and duration of
More informationAntibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE
Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationIt s Time to Regulate Antimicrobial Stewardship Standards in Acute Care Settings. Emily Heil, PharmD, BCPS-AQ ID, AAHIVP
It s Time to Regulate Antimicrobial Stewardship Standards in Acute Care Settings Emily Heil, PharmD, BCPS-AQ ID, AAHIVP Conflict of Interest I have no conflicts of interest to disclose related to the content
More informationAntimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance
Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance Natalie Weber, PharmD PGY2 Critical Care Pharmacy Resident September 22, 2016 The speaker has no actual or potential conflicts of
More informationAntimicrobial Stewardship: Guidelines for its Implementation
Antimicrobial Stewardship: Guidelines for its Implementation Loliet Gonzalez Martinez, Pharm.D. Palmetto General Hospital PGY-1 Pharmacy Resident Disclosure The author of this presentation has nothing
More informationProtecting Patients and Antimicrobials Best Practices in Stewardship
Protecting Patients and Antimicrobials Best Practices in Stewardship Jonathan Hand MD Director, Antimicrobial Stewardship Program Director, Transplant Infectious Diseases Department of Infectious Diseases
More informationAntimicrobial Stewardship Esperienza Torinese
Pisa 15 Novembre 2016 Antimicrobial Stewardship Esperienza Torinese Francesco G. De Rosa Dipartimento di Scienze Mediche Università di Torino Antimicrobial Stewardship First introduced by Dale Gerding
More informationANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT
ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT CLINICAL GUIDELINES ID TAG Title: Prepared by Specialty / Division: Directorate: Antimicrobial Stewardship
More informationAntimicrobial Stewardship
Antimicrobial Stewardship Annual Report 2015-2016 Prepared by the Fraser Health Antimicrobial Stewardship Program August 2016 Contents Executive Summary... 3 Background... 4 ASP Team Members... 5 Ackowledgements...
More informationANTIBIOTIC STEWARDSHIP. Brian Mayhue, Pharm D, CGP Director of Pharmacy Palm Beach Gardens Medical Center
ANTIBIOTIC STEWARDSHIP Brian Mayhue, Pharm D, CGP Director of Pharmacy Palm Beach Gardens Medical Center Antibiotic Resistance It is not difficult to make microbes resistant to penicillin in the laboratory
More informationAddressing ABX Resistance
Antimicrobial Stewardship: When to Study, and When to Act Addressing ABX Resistance Curtailing ABX Resistance Antimicrobial Use Interventions Agricultural Animals Humans Infection Control Interventions
More informationUpdate on current SAPG projects
Update on current SAPG projects SAPG Network event 2 nd November 2018 Jacqueline Sneddon Scottish Antimicrobial Prescribing Group Safeguarding antibiotics for Scotland, now and for the future Antifungal
More informationAntibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship
Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship J. Hudson Garrett Jr., PhD, MSN, MPH, FNP-BC, PLNC, CDONA, IP-BC, GDCN, CDP, CADDCT, CALN, VA-BC, AS-BC,
More informationGhinwa Dumyati, MD Christina Felsen, MPH University of Rochester Medical Center
Ghinwa Dumyati, MD Christina Felsen, MPH University of Rochester Medical Center How do you decide where to start? Start small; core elements recommend you focus on one thing at a time Use data to help
More informationAn audit of the quality of antimicrobial prescribing
An audit of the quality of antimicrobial prescribing Rakhee Patel, Antimicrobial Pharmacist Alison Williams, Antimicrobial Technician & Dr Armando Gonzalez-Ruiz May 2011 ICE Score 2 Introduction & Aims
More informationAntibiotic Stewardship at MetroWest Medical Center. Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee
Antibiotic Stewardship at MetroWest Medical Center Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee Antibiotic Stewardship Committee Subcommittee of Pharmacy and Therapeutics. Also
More informationThe Nuts and Bolts of Antibiograms in Long-Term Care Facilities
The Nuts and Bolts of Antibiograms in Long-Term Care Facilities J. Kristie Johnson, Ph.D., D(ABMM) Professor, Department of Pathology University of Maryland School of Medicine Director, Microbiology Laboratories
More information2016/LSIF/FOR/007 Improving Antimicrobial Use and Awareness in Korea
2016/LSIF/FOR/007 Improving Antimicrobial Use and Awareness in Korea Submitted by: Asia Pacific Foundation for Infectious Diseases Policy Forum on Strengthening Surveillance and Laboratory Capacity to
More informationWELSH HEALTH CIRCULAR
WELSH HEALTH CIRCULAR WHC/2018/020 Issue Date: 4 May 2018 STATUS: ACTION & INFORMATION CATEGORY: QUALITY AND SAFETY Title: AMR IMPROVEMENT GOALS & HCAI REDUCTION EXPECTATIONS BY MARCH 2019: PRIMARY & SECONDARY
More informationObjective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest
Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial
More informationPreventing and Responding to Antibiotic Resistant Infections in New Hampshire
Preventing and Responding to Antibiotic Resistant Infections in New Hampshire Benjamin P. Chan, MD, MPH NH Dept. of Health & Human Services Division of Public Health Services May 23, 2017 To bring a greater
More informationClinical Guideline. District Infectious Diseases Management. Go to Guideline. District Infectious Diseases Management CG 18_24
Clinical Guideline District Infectious Diseases Management Sites where Clinical Guideline applies All facilities This Clinical Guideline applies to: 1. Adults Yes 2. Children up to 16 years Yes 3. Neonates
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationStewardship: Challenges & Opportunities in the Gulf Region
Stewardship: Challenges & Opportunities in the Gulf Region Mushira Enani, MBBS, FRCPE, FACP,CIC Head- Infectious Disease Section King Fahad Medical City Outline Background of Healthcare system in GCC GCC
More informationAntimicrobial Stewardship Program: Local Experience
Antimicrobial Stewardship Program: Local Experience Dr. WU Tak Chiu Associate Consultant Division of Infectious Diseases Department of Medicine Queen Elizabeth Hospital 18th January 2011 QUEEN ELIZABETH
More informationAntibiotic Stewardship Beyond Hospital Walls
Antibiotic Stewardship Beyond Hospital Walls Katie Burenheide Foster, PharmD, MS, BCPS, FCCM Pharmacy Clinical Manager & PGY1 Pharmacy Residency Director OBJECTIVES 1. Review what Antibiotic Stewardship
More informationCanadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING HIP AND KNEE ARTHROPLASTY
Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING HIP AND KNEE ARTHROPLASTY FINAL Working Group: Dominik Mertz (Chair) Elizabeth Henderson, Johan
More informationAntimicrobial Stewardship Program
Antimicrobial Stewardship Program David R. Woodard, MSc, FSHEA, CIC CDC: Antibiotic Resistance Threats in the United States, 2013 http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ CDC Threat Levels
More informationOur Team. Stewarding One of Healthcare s Anchors: Antimicrobials. Clinical Operational Research Learners
tewarding One of Healthcare s Anchors: Antimicrobials Andrew M. Morris, MD M Antimicrobial tewardship Program inai Health ystem University Health Network andrew.morris@sinaihealthsystem.ca @APphysician
More informationMAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges
Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control
More informationToday s webinar will begin in a few minutes.
Today s webinar will begin in a few minutes. Please press *6 to mute your line or use the mute button on your phone. If you have questions for the presenter or need to contact TCPS staff, type your comments
More information